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late gadolinium enhancement for analysis of necrosis were obtained. The left
ventricle was divided into 16 segments (ASE) for analysis of the presence of
oedema and necrosis. For comparative analysis with the ECG, 4 locations were
considered at CMR: anterior (anterior septum and anterior wall), lateral (lateral
and posterior walls), inferior (inferior wall and inferior septum) and generalized.
The criteria used to define topographic concordance of ECG with CMR were: the
correlation of ≥ 1 location in each patient if ≤ 2 locations affected and if there
were widespread ECG changes there would have to be ≥ 2 locations exhibiting
changes at CMR.
Results: The sensitivity of the ECG for the detection of myocarditis was 86.4%.
The sensitivity of ST-segment elevation was 77.3% (N = 17) and inversion of T
waves was 50% (N = 11). There was topographic agreement between: ST seg-
ment elevation and oedema in 47.1%, T wave inversion and oedema in 90.9%,
ST-segment elevation or inversion of T waves with oedema in 79%. There was ST-
segment elevation topographically related to myocardial necrosis in 64.7% and
there was necrosis in 90,9% of the locations exhibiting T wave inversion. There
was either ST-segment elevation or inversion of T waves in 84.2% of the locations
that had evidence of necrosis in CMR.
Conclusions: ECG changes usually attributed to myocardial infarction have
proved to have good sensitivity for the detection of myocarditis. Either ST-
elevation or T wave invertion were good predictors of the location of edema and
necrosis at CMR.
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Background: High coronary artery calcium score (CACS) is associated with
moderate to high risk of future cardiovascular events, even in asymptomatic in-
dividuals. Studies describing a limited diagnostic accuracy of fluoroscopy were
performed using previous generation x-rays systems with conventional image
intensifier chains. We investigated digital fluoroscopy’s accuracy for detection
of CACS using a flat panel digital detector (FPDD) fluoroscopy system. Mul-
tislice computed tomography (MSCT) derived CACS was used as a reference
method.
Methods: Asymptomatic volunteers without known coronary artery disease
(CAD) and with a normal ECG underwent ECG-gated low radiation MSCT. CACS
was calculated using the Agaston method and subjects were classidied into 4 risk
categories for CAD: low (CACS 0-10), intermediate (CACS 11-100), high (CACS
101-400) and very high (CACS>400) risk. A cutoff of 10 was used to transform
the results of the reference method into a binary variable. Cardiac fluoroscopic
imaging was performed in LAO 45° and CRANIAL 15° view on the same day,
and analyzed blindly by two independent investigators. Fluoroscopy results were
classified as absent (0), mild (1), moderate (2) and severe calcification (3).
Results: We studied 151 individuals (66.5% men, 70.9% current/ex smokers,
62.3% dyslipidemics, 39.1% hypertensives, 13.2% diabetics) with a mean age of
53.1±7.6 years. Inter-observer and intra-observer agreement for fluoroscopy’s
results was 75.5% and 82.4% respectively (weighted kappa coefficient 0.724
and 0.812 respectively). ROC curve revealed that detection of any calcium on
fluoroscopy (score >0) had 85.9% sensitivity and 87.3% specificity for identify-
ing individuals with Agaston CACS >10 (AUC 0.889, p<0.001), with 83.3% and
89.4% positive and negative predictive value respectively. A fluoroscopy score >
1 had 100% sensitivity and 85.8% specificity for identifying individuals with Agas-
ton CACS >400 (AUC 0.975, p<0.001), with 33.3% and 100.0% positive and
negative predictive value respectively.
Conclusion: FPDD fluoroscopy demonstrates high sensitivity and specificity for
detection of coronary calcium compared with MSCT. In individuals with an Agas-
ton CACS>400 this technique has an excellent negative prognostic value and
could substitute MSCT, especially in centers where the latter is not available.
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Purpose: Myocardial perfusion scintigraphy (MPS) with pharmacological stimu-
lus has been validated, through the years, as an efficient non-invasive imaging
technique for the diagnosis of myocardial ischemia. However, few data are avail-
able regarding MPS use in patients with right ventricular pacing (RVP). Asyn-
chronous activation resulting from right ventricular apical pacing has been pointed
out as the cause of left ventricular dysfunction and changes in myocardial perfu-
sion despite normal coronary arteries. We sought to evaluate the positive predic-
tive value (PPV) and prognostic value of MPS with pharmacological stimulus in
patients with RVP.
Methods: Sixty patients with RVP consecutively submitted to MPS with pharma-
cological stimulus were reviewed. All MPS were ordered for the diagnostic work-
up of retrosternal pain. The pharmacological stimulus used was adenosine and all
patients had permanent RVP. We determined the PPV of MPS in patients submit-
ted to coronariography after the detection of ischemia by MPS. For the evaluation
of the prognostic value of MPS, we compared the patients with reversible defects
on MPS to those without reversible defects. The end points were the composite
end points of all cause mortality, hospitalization for acute coronary syndrome and
non-scheduled coronary revascularization at one and three years.
Results: Of the sixty patients analyzed, MPS identified ischemia in twenty-six
individuals. Fourteen patients presenting ischemia in MPS underwent coronari-
ography. New or worsen coronary heart disease was identified in seven patients;
the remaining seven patients had normal coronary arteries. Considering the four-
teen patients submitted to coronariography, the PPV of MPS was fifty percent.
Most of the false positive defects were localized to the apical, inferior and septal
walls. When comparing patients with ischemia (n=26) and those without ischemia
(n=34) on MPS, the former presented a trend to higher number of adverse events
at one year (23.8% vs 6.3%; p=0.1) and at three years (28.6% vs 7.1%; p=0.08).
Conclusions: RVP resulted in perfusion defects not related to the presence of
coronary heart disease, mainly in apical, inferior and septal walls. In the popu-
lation studied, the PPV of MPS for the detection of coronary heart disease in
patients with RVP was fifty percent. Reversible perfusion defects in MPS may
have prognostic value.
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Background: Patients (pts) with cardiac syndrome X (CSX) have excellent long-
term prognosis, but a significant number shows worsening angina despite multi-
drug treatment. In CSX pts, previous studies found a significant scintigraphic im-
pairment of cardiac uptake of 123-I-metaiodobenzylguanidine (MIBG), indicating
abnormal function of cardiac adrenergic nerve fibres. In this study we investigated
whether cardiac MIBG results can predict clinical outcome in CSX pts.
Methods: We performed cardiac MIBG scintigraphy in 40 CSX pts (age 58±5,
14 M). Cardiac MIBG uptake was measured by the heart/mediastinum (H/M) ratio
and by SPECT regional MIBG uptake score (higher values=lower uptake). Clinical
findings, exercise stress test parameters, SestaMIBI stress myocardial scintigra-
phy and C-reactive protein serum levels were also assessed in all pts. End-points
included readmission for angina, worsening angina, repetition of coronary angiog-
raphy and quality of life, assessed by a visual analogic scale (Euro-QoL) gradu-
ated from 0 (worst) to 100 (best).
Results: At a follow-up of 79±47 months (range 36-144), no patient died or had
acute myocardial infarction. Hospital readmission for angina occurred in 25 pts
(62%) and 23 pts (57%) underwent coronary angiography. Angina was judged
improved over time by 15 pts (37%), whereas 23 pts (57%) reported worsening
angina. Values of MIBG variables according to clinical end-points are shown in
the Table. A significant correlation was found between Euro-QoL scale and H/M
ratio (r=0.44; p=0.005) and MIBG score (r=-0.70; p<0.001). No other clinical or
laboratory variable showed significant relation with end-points.
H/M ratio P MIBG score P
≥2 readmissions for angina Yes (n=14) 1.57±0.50 0.13 43±30 0.004
No (n=26) 1.75±0.23 19±18
Repetition of coronary angiography Yes (n=23) 1.63±0.39 0.17 37±28 0.001
No (n=17) 1.79±0.25 11±7
Worsening angina Yes (n=23) 1.62±0.41 0.15 38±29 0.001
No (n=17) 1.78±0.24 13±8
Conclusion: Our data show that, in CSX pts, the extension of cardiac MIBG
uptake defects can identify those with a worse outcome of symptomatic state.
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Background: Trastuzumab has been shown to benefit patients with HER2-
positive breast cancer, but can induce cardiotoxicity, particularly when com-
bined with anthracyclins. However, little is known about the predictive factors of
trastuzumab mediated cardiotoxicity.
Aim: Evaluation of left ventricular diastolic function obtained by Radionuclide An-
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